Biosimilars Archives - Express Pharma

Teva and Sandoz make major push to biosimilars

Dr Reddy’s lines up Rs 1,500 crore capex to focus on biosimilars and injectables

Biocon Biologics to acquire Viatris’ biosimilars assets for up to $3.335 billion

CPhI and Informa Pharma Intelligence conclude 3rd Biopharma Conclave

A Superstar marriage?

Cipla takes deal route with Alvotech to enter Australian autoimmune biosimilars market: GlobalData

Mylan-UpJohn merger as Viatris provides opportunity to focus on biosimilar launch and uptake

Abu Dhabi firm, ADQ invests Rs 555 crores in Biocon Biologics

Xentria gets US FDA orphan drug designation for XTMAB-16 in sarcoidosis

Biocon Biologics gets Rs 1, 125 cr capital injection from Goldman Sachs